Effects of Intermittent Fasting on Response to Tyrosine Kinase Inhibitors (TKIs) in Patients With Chronic Myeloid Leukemia: An Outcome of European LeukemiaNet Project

by Mohamed A. Yassin MBBS, MSc, Rola S. Ghasoub BSC, Mahmood B. Aldapt MD, Mohammad A. Abdulla MD, Prem Chandra PhD, Hawraa M. Shwaylia MD, Abdulqadir J. Nashwan BSN, MSN, Nancy A. Kassem BSC, Susanna J. Akiki PhD
Published 2021-04-01

Is Adherence to Imatinib Mesylate Treatment among Patients with Chronic Myeloid Leukemia Associated with Better Clinical Outcomes in Qatar?

by Nader I. Al-Dewik, Hisham M. Morsi, Muthanna M. Samara, Rola S. Ghasoub, Cinquea C. Gnanam, Subi K. Bhaskaran, Abdulqadir J. Nashwan, Rana M. Al-Jurf, Mohamed A. Ismail, Mohammed M. Alsharshani, Ali A. Alsayab, Tawfeg I. Ben-Omran, Rani B. Khatib, Mohamed A. Yassin
Published 2016-01-01

Is Adherence to Imatinib Mesylate Treatment Among Patients with Chronic Myeloid Leukemia Associated with Better Clinical Outcomes in Qatar?

by Nader I. Al-Dewik, Hisham M. Morsi, Muthanna M. Samara, Rola S. Ghasoub, Cinquea C. Gnanam, Subi K. Bhaskaran, Abdulqadir J. Nashwan, Rana M. Al-Jurf, Mohamed A. Ismail, Mohammed M. AlSharshani, Ali A. AlSayab, Tawfeg I. Ben-Omran, Rani B. Khatib, Mohamed A. Yassin
Published 2016-10-01